Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer

被引：0
|
作者：
Dirk Bottke
Detlef Bartkowiak
Alessandra Siegmann
Reinhard Thamm
Dirk Böhmer
Volker Budach
Thomas Wiegel
机构：
[1] Fachbereich Strahlentherapie,MVZ Klinikum Esslingen GmbH
[2] University Hospital Ulm,Department of Radiation Oncology and Radiotherapy
[3] Charité Universitätsmedizin Berlin Campus Benjamin Franklin,Department of Radiation Oncology and Radiotherapy
来源：
Prostate Cancer and Prostatic Diseases | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：344 / 349
页数：5
相关论文
共 50 条
  • [11] Prostate-specific antigen (PSA) bounce following salvage radiotherapy to the prostate bed in a patient with prostate cancer post-prostatectomy
    Rowe, Michael
    Adamson, Ellis
    McGrane, John
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2020, 9 (04) : 217 - 220
  • [12] Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy:: From the CaPSURE™ database
    Macdonald, O. Kenneth
    D'Amico, Anthony V.
    Sadetsky, Natalia
    Shrieve, Dennis C.
    Carroll, Peter R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (03) : 271 - 275
  • [13] Value of initial prostate-specific antigen (PSA) for predicting the post-prostatectomy PSA progression in patients with initial PSA≥20 ng/ml and no distant metastases
    Choi, Young Deuk
    Ham, Won Sik
    Cho, Kang Su
    Jung, Won Suk
    Kim, Sang Woon
    Lee, Joong Shik
    Kim, Dong Suk
    JOURNAL OF UROLOGY, 2008, 179 (04): : 401 - 401
  • [14] Matched pair analysis of salvage radiotherapy vs observation for post-prostatectomy PSA recurrence
    Wiegel, T.
    Tilki, D.
    Preisser, F.
    Pompe, R.
    Chun, F.
    Graefen, M.
    Huland, H.
    Siegmann, A.
    Boehmer, D.
    Budach, V.
    Thamm, R.
    Bartkowiak, D.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S372 - S373
  • [15] Better Prognosis by early Salvage Radiotherapy (PSA &lt;0.2 ng/ml) in PSA-Progression after Prostate Cancer Surgery
    Thamm, R.
    Bartkowiak, D.
    Bottke, D.
    Siegmann, A.
    Boehmer, D.
    Budach, V
    Wiegel, T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 40 - 40
  • [16] Impact of persistent PSA in salvage radical prostatectomy patients for recurrent prostate cancer
    Preisser, F.
    Pose, R. M.
    Heinze, A.
    Steuber, T.
    Michl, U.
    Salomon, G.
    Chun, F. K. H.
    Graefen, M.
    Tilki, D.
    EUROPEAN UROLOGY, 2022, 81 : S285 - S285
  • [17] Prognostic significance of the PSA nadir after salvage radiotherapy following radical prostatectomy in prostate cancer.
    Wiegel, Thomas
    Bartkowiak, Detlef
    Bottke, Dirk
    Siegmann, Alessandra
    Budach, Volker
    Hinkelbein, Wolfgang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [18] Serum PSA evaluations during salvage radiotherapy for post-prostatectomy biochemical failures as prognosticators for treatment outcomes
    Do, T
    Dave, G
    Parker, R
    Kagan, AR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (05): : 1220 - 1225
  • [19] USE OF PSA SLOPE TO GUIDE ADJUVANT RADIOTHERAPY IN POST-PROSTATECTOMY PROSTATE CANCER HAS POTENTIAL TO BE COST EFFECTIVE
    Reed, S. D.
    Stewart, Biehn S.
    Scales, C. D.
    Moul, J. W.
    VALUE IN HEALTH, 2014, 17 (03) : A86 - A86
  • [20] PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
    Nantia Solomonidou
    Daphnie Germanou
    Iosif Strouthos
    Efstratios Karagiannis
    Andrea Farolfi
    Stefan A. Koerber
    Juergen Debus
    Jan C. Peeken
    Marco E. Vogel
    Alexis Vrachimis
    Simon K. B. Spohn
    Mohamed Shelan
    Daniel Aebersold
    Anca-Ligia Grosu
    Francesco Ceci
    Stephanie G. C. Kroeze
    Matthias Guckenberger
    Stefano Fanti
    Claus Belka
    George Hruby
    S. Scharl
    Thomas Wiegel
    Peter Bartenstein
    Christoph Henkenberens
    Louise Emmett
    Nina Sophie Schmidt-Hegemann
    Konstantinos Ferentinos
    Constantinos Zamboglou
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2529 - 2536
12345